Neurofeedback therapy is a non-invasive, brain-based treatment that helps individuals learn to regulate their own brain activity. By training specific brainwave patterns associated with attention, focus, emotional regulation, and sleep, neurofeedback aims to create lasting changes in brain function and behaviour.
At Smart TMS, we use neurofeedback treatment for ADHD and insomnia to help individuals improve concentration, sleep quality, and overall wellbeing. Unlike many traditional pharmaceutical approaches, neurofeedback focuses on teaching the brain new patterns rather than relying on ongoing symptom management.
While ADHD medication remains a common treatment option, concerns about side effects and long-term effectiveness have led many people to explore alternative approaches. Recent research suggests that interventions targeting sustainable behavioural and neurological change may offer significant benefits for people living with ADHD and related mental health challenges.
When choosing an ADHD treatment, effectiveness is only one consideration. Long-term wellbeing, quality of life, and the potential for side effects are equally important.
Common side effects associated with ADHD medications can include:
(Lange, 2017)
While medication can effectively reduce symptoms such as inattention and hyperactivity, these side effects may negatively impact day-to-day functioning and overall wellbeing.
One of the major advantages of neurofeedback therapy for ADHD is its favourable safety profile. As a non-invasive treatment, neurofeedback is associated with minimal side effects and focuses on helping the brain develop healthier patterns of self-regulation.
ADHD is increasingly recognised as a lifelong neurodevelopmental condition that can affect multiple aspects of health and daily functioning.
Research shows that individuals with ADHD are at increased risk of:
(French et al., 2024)
These findings highlight the importance of treatments that support meaningful, long-term improvements rather than simply providing temporary symptom relief.
Despite widespread prescribing of ADHD medication, evidence supporting sustained long-term symptom improvement remains limited.
The landmark NIMH Multimodal Treatment Study found that while medication appeared to offer superior symptom improvement after 14 months, these benefits diminished over time. Follow-up assessments conducted six to eight years later found that many participants continued to experience significant levels of inattention and hyperactivity compared to individuals without ADHD (Jensen et al., 2007).
This raises an important question: if symptoms return when medication is discontinued, are we treating ADHD or managing symptoms while treatment continues?
Increasingly, researchers argue that successful treatment should focus on long-term remission, improved daily functioning, and enhanced quality of life rather than indefinite symptom suppression.
This is where neurofeedback for ADHD offers a unique advantage.
Unlike medication, which generally works while actively being taken, neurofeedback uses principles of operant conditioning and brain training to help individuals learn how to regulate their own brain activity. The goal is to create lasting neurological change by strengthening healthier brainwave patterns associated with attention, focus, impulse control, and sleep regulation.
Because neurofeedback is a skill-based intervention, many of the benefits may continue after treatment has ended.
Research suggests that improvements in ADHD symptoms following neurofeedback training can be maintained—and in some cases strengthened—for six to twelve months after treatment completion (Van Doren et al., 2019).
For individuals experiencing both ADHD and sleep difficulties, neurofeedback may also support improvements in:
By targeting underlying brain activity patterns associated with ADHD, neurofeedback aims to address core neurological processes rather than simply suppress symptoms.
As awareness grows around the importance of sustainable mental health interventions, neurofeedback is becoming an increasingly popular option for individuals seeking a non-medication ADHD treatment, insomnia treatment, or complementary mental health therapy.
While medication may remain appropriate for many people, neurofeedback offers a promising alternative that focuses on long-term brain regulation, symptom improvement, and overall quality of life.
At Smart TMS, we provide evidence-based neurofeedback treatment designed to support individuals living with:
By helping the brain learn healthier patterns of functioning, neurofeedback may support lasting improvements in attention, sleep, and mental wellbeing.
Written by Isabel, Smart TMS London practitioner and Nikki, Smart TMS Birmingham practitioner
Becker, S. P. (2020). ADHD and sleep: Recent advances and future directions. Current Opinion in Psychology, Sleep & Psychopathology, 34, 50–56. https://doi.org/10.1016/j.copsyc.2019.09.006
Elaine Pinggal, James Jackson, Anikó Kusztor, David Chapman, Jennifer Windt, Sean P.A. Drummond, Tim J. Silk, Mark A. Bellgrove, Thomas Andrillon (2025) Sleep-like Slow Waves During Wakefulness Mediate Attention and Vigilance Difficulties in Adult Attention-Deficit/Hyperactivity Disorder https://doi.org/10.1101/2025.07.27.666103
French, B., Nalbant, G., Wright, H., Sayal, K., Daley, D., Groom, M. J., Cassidy, S., & Hall, C. L. (2024). The impacts associated with having ADHD: An umbrella review. Frontiers in Psychiatry, 15. https://doi.org/10.3389/fpsyt.2024.1343314
Gruber, R. (2012). Sleep patterns and the risk for ADHD: A review. Nature and Science of Sleep, 73. https://doi.org/10.2147/NSS.S31269
Jensen PS, Arnold LE, Swanson JM, Vitiello B, Abikoff HB, Greenhill LL, et al. 3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry 2007; 46: 989–1002.
Lange, K. W. (2017). The treatment of attention deficit hyperactivity disorder has no proven long-term benefits but possible adverse effects. Movement and Nutrition in Health and Disease, 1. https://doi.org/10.5283/mnhd.4
Lazzaro, G., Galassi, P., Bacaro, V., Vicari, S., & Menghini, D. (2024). Clinical characterization of children and adolescents with ADHD and sleep disturbances. European Archives of Psychiatry and Clinical Neuroscience, 275(7), 1913–1924. https://doi.org/10.1007/s00406-024-01921-w
Strehl, U., Aggensteiner, P., Wachtlin, D., Brandeis, D., Albrecht, B., Arana, M., Bach, C., Banaschewski, T., Bogen, T., Flaig-Röhr, A., Freitag, C. M., Fuchsenberger, Y., Gest, S., Gevensleben, H., Herde, L., Hohmann, S., Legenbauer, T., Marx, A.-M., Millenet, S., … Holtmann, M. (2017). Neurofeedback of slow cortical potentials in children with attention-deficit/hyperactivity disorder: A multicenter randomized trial controlling for unspecific effects. Frontiers in Human Neuroscience, 11, 135. https://doi.org/10.3389/fnhum.2017.00135
Van Doren, J., Arns, M., Heinrich, H., Vollebregt, M. A., Strehl, U., & K. Loo, S. (2019). Sustained effects of neurofeedback in ADHD: A systematic review and meta-analysis. European Child & Adolescent Psychiatry, 28(3), 293–305. https://doi.org/10.1007/s00787-018-1121-4
Xian P, Sheng X, Liu S, Liu Z, Guo X. Sleep dysregulation in ADHD children: a systematic review and meta-analysis. Psychological Medicine. 2025;55:e321. doi:10.1017/S0033291725102158